MedTrace Logo

Preventive Care System Application Effectiveness Study on the Treatment of Diabetic Patients in Bandung

NCT05657769 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 160

Last updated 2023-04-19

No results posted yet for this study

Summary

Randomized, unblinded, controlled, two arms parallel group, prospective intervention study

Conditions

  • Diabetes Mellitus, Type 2

Interventions

DEVICE

Medwell Preventive Care Application

Regular diabetes treatment with additional Medwell application and wearable device.

DEVICE

Manual Records

Regular diabetes treatment only with a diary card to record daily activities manually.

Sponsors & Collaborators

  • Immanuel Hospital

    collaborator UNKNOWN

  • Prodia the CRO

    collaborator UNKNOWN

  • PT Bio Farma

    lead INDUSTRY

Principal Investigators

  • Ratih Nursiana · RS Immanuel

  • Indahwaty Indahwaty · RS Immanuel

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-11-12
Primary Completion
2023-05-30
Completion
2023-05-30

Countries

  • Indonesia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05657769 on ClinicalTrials.gov